Ãû´Ê½âÊÍ n@9*>DU
1:I47/
1¡¢Í»´¥µçλ£ºÉñ¾µÝÖÊ´ÓÍ»´¥Ç°Ä¤Í¨¹ý°ûÍÂ×÷ÓÃÊÍ·Å£¬¿ç¹ýÍ»´¥¼ä϶£¬×÷ÓÃÓÚÍ»´¥ºóÄ££¬ÔÚµçÉúÀíÑо¿ÉÏ£¬¿ÉÒԹ۲쵽ͻ´¥ºóÄ£ÉÏÒýÆðÒ»¸ö¶ÌÔݵصçλ±ä»¯¡£°üÀ¨EPSPÓëIPSP¡£ }nrl2yp:%
VH&6Tm1
À©Õ¹£ºÍ»´¥synapse Éñ¾ÔªÓëÉñ¾ÔªÖ®¼äµÄ»úÄÜÁ¬½Óµã¡£ KF' $D:\
Eeemy*U
2¡¢Epsp:ÐË·ÜÐÔÍ»´¥ºóµçλ(Excitatory Postsynaptic Potential,EPSP)ÊǵÝÖÊÒýÆðµÄÍ»´¥ºóĤµÄ¶ÌÔÝÈ¥¼«»¯¡£EPSPÊÇÓɶÔNa+ºÍK+¶¼Í¨Í¸µÄ¹È°±ËáÃÅ¿ØÀë×ÓͨµÀ¿ª·ÅËùÐγɡ£ +we3BE.
k(>hboR5n
¹È°±ËáÃÅ¿ØÀë×ÓͨµÀ½éµ¼Á½ÖÖ²»Í¬Ê±³ÌµÄEPSC(ExcitatoryPostsynaptic Current) 5f&+(Wqw
:cv_G;?
AMPA/KAÊÜÌåͨµÀ½éµ¼¿ìʱ³ÌµÄEPSC gie}k)&M
T7E9l
NMDAÊÜÌåͨµÀ½éµ¼Âýʱ³ÌµÄEPSC cX$ Pq
~2Jvb[IM
IPSP:ÒÖÖÆÐÔÍ»´¥ºóµçλ(Inhibitory Postsynaptic Potential,IPSP)ÊǵÝÖÊÒýÆðµÄÍ»´¥ºóĤµÄ¶ÌÔݳ¬¼«»¯. ;qT~81
vJg|}]h>L
IPSPÊÇÓɶÔCl-ͨ͸µÄGABAºÍGlycineÃÅ¿ØÀë×ÓͨµÀ¿ª·ÅËùÐγɡ£ m09
Bds
]m0MbA
3¡¢SynapseÍ»´¥£ºµçÍ»´¥(Electrical Synapse)ºÍ»¯Ñ§ÐÔÍ»´¥(Chemical Synapse)£¬µ«ÒÔ»¯Ñ§ÐÔÍ»´¥ÎªÖ÷¡£µçÍ»´¥Í¨¹ý·ì϶Á¬½Ó(gapjunction)Ö±½ÓÍê³Éϸ°û¼äµÄµçÐÅÏ¢´«µÝ¡£»¯Ñ§ÐÔÍ»´¥´«µÝ±ØÐëÒÀÀµÓÚÉñ¾µÝÖÊ(Neurotransmitters)»òÉñ¾ëÄ(Neuropeptides)×÷ÓÃÓÚÍ»´¥ºóĤµÄÊÜÌå¶øÍê³Éϸ°û¼äµÄÐÅÏ¢´«µÝ¡£ 9)={p9FZY
4¡¢Action potential¶¯×÷µçλ£ºÊÇ´¦ÓÚ¾²Ï¢µçλ״̬µÄϸ°ûĤÊܵ½Êʵ±´Ì¼¤¶ø²úÉúµÄ£¬Ë²¼äʹ°ûÄÚµçλÏà¶ÔÓÚ°ûÍâΪÕýµçλ¡£ÊÇÒ»´Î¿ÉÄæµÄ¡¢¿É´«µ¼µÄµçλ±ä»¯ r0=Aru5n
1=C>S2q
Àë×Ó»ù´¡£ºµçѹÃÅ¿ØÄÆÍ¨µÀ½á¹¹ d,j"8\@
W2Y%PD9a
Ó°Ï춯×÷µçλ´«µ¼µÄÒòËØ£ºÖáÍ»´Öϸ£»ÖáÍ»ÉÏÄÆÍ¨µÀµÄÃܶȣ»ËèÇʺÍÌøÔ¾´«µ¼¡£ AtNu:U$
b?U!<s.
¶¯×÷µçλËù¾ßÓеÄÌØÐÔµÄÒâÒå:ÏÞÖÆ´«µ¼ÆµÂÊ;²»»á·¢ÉúÖØµþ×ܺÍ;²»»áÔÚϸ°û±íÃæÀ´»ØÍù¸´Õñµ´¡£ qv<[f=X9|
9H5S@w[je
Resting potential¾²Ï¢µçλ£ºÉñ¾ÔªÎ´Êܴ̼¤Ê±´æÔÚÓÚϸ°ûĤÄÚÍâÁ½²àµÄµçλ²î¡£ A-:58Qau+
5¡¢Electroencephhy-EEGÄÔµçͼ£ºÊǽ«ÄÔϸ°ûµÄ×Ô·¢·Åµç»î¶¯Í¨¹ýµç×Ó·Å´óÆ÷·Å´ó²¢Ãè¼ÇÔÚÖ½ÉϵÄÒ»Öֿ͹ۼǼ´óÄÔ»úÄÜ״̬µÄ¼ì²é·½·¨¡£ÊÇÒ»ÖÖÎÞ´´ÆÀ¼Û·½·¨¡£ @;m7u
mq@2zE`.(
7¡¢Éñ¾µ÷ÖÊ(Neuromodulator) £ºÓÐһЩÉñ¾µ÷½ÚÎï±¾Éí²¢²»Ö±½Ó´¥·¢ËùÖ§Åäϸ°ûµÄ¹¦ÄÜЧӦ£¬Ö»Êǵ÷ÖÆ´«Í³µÝÖʵÄ×÷Óᣠ+,=DUsI}
Y>z~0$
¿ÉΪÉñ¾Ï¸°û¡¢½ºÖÊϸ°û»òÆäËü·ÖÃÚϸ°ûËùÊÍ·Å£¬¶ÔÖ÷µÝÖÊÆðµ÷ÖÆ×÷Óᣠ:|J'HCth
9W$
FX
±¾Éí²»Ö±½Ó¸ºÔð¿çÍ»´¥ÐźŴ«µÝ»ò²»Ö±½ÓÒýÆðЧӦϸ°ûµÄ¹¦Äܸı䣬¶øÊǵ÷½ÚÐÅÏ¢´«µÝµÄЧÂÊ£¬ÔöÇ¿»òÏ÷ÈõµÝÖʵÄЧӦ¡£ j["b*X`8G
ES72yh]
¼ä½Óµ÷ÖÆÖ÷µÝÖÊÔÚÍ»´¥Ç°Éñ¾Ä©ÉÒµÄÊͷż°Æä»ù´¡»î¶¯Ë®Æ½¡£ 6Zwrk-,A
DYlu`j_ux
Ó°ÏìÍ»´¥ºóЧӦϸ°û¶ÔµÝÖʵķ´Ó¦ÐÔ£¬¶ÔµÝÖʵÄЧӦÆðµ÷ÖÆ×÷Óᣠ@K`2y'#b
p(/PG+
8¡¢ÀÄÓÃ(Abuse)Ö¸Ò»ÖÖ·ÇÒ½ÁÆËùÐèµÄ²»Á¼ÓÃÒ©·½Ê½£¬ÓÉÓÚ·´¸´Ê¹ÓÃÒ©Îïµ¼ÖÂÁËÃ÷ÏԵIJ»Á¼ºó¹û£¬Èç²»ÄÜÍê³ÉÖØÒªµÄ¹¤×÷¡¢Ñ§Òµ£¬Ëðº¦ÁËÇûÌå¡¢ÐÄÀí½¡¿µ£¬µ¼Ö·¨ÂÉÉϵÄÎÊÌâµÈ¡£ 4[t1"s~Wg
H)S&sx#q]
9¡¢ÄÍÊÜÐÔ(Tolerance)Ö¸Ò©ÎïʹÓÃÕß±ØÐëÔö¼Ó¼ÁÁ¿·½ÄÜ»ñµÃËùÐèµÄЧ¹û£¬ÈçÈÔÒÔÔÀ´µÄ¼ÁÁ¿Ôò´ï²»µ½Ëù×·ÇóµÄЧ¹û¡£ @O b$w1c
L 1=HD
10¡¢¶¯»úMotivation£ºÖ¸ÐÐΪÆð¶¯Ç°Éñ¾¸ß¼¶²¿Î»ÄÇÖÖÓëµ¼Ö¸ÃÐÐΪ·¢ÉúÓйصÄ˼ά»î¶¯£¬ÊÇÒâÏò¡¢Çý¶¯µÄ¾ÛºÏ£¬Ëü×îÖÕµ¼ÖÂÐÐΪµÄ³öÏÖ¡£ o9+"6V|.
1wpT"5B
11¡¢½ä¶Ï×ÛºÏÖ¢£¨withdrawal syndrome£© 1euL+zeh
Y
3G$(+i8
ָֹͣʹÓÃÒ©Îï»ò¼õÉÙʹÓÃÒ©Îïºó»òʹÓÃÞ׿¹¼ÁºóËù³öÏÖµÄÌØÊâµÄÐÄÀíÉúÀí֢״Ⱥ¡£²»Í¬µÄÒ©ÎïËùÖµĽä¶ÏÖ¢×´ÒòÆäÒ©ÀíÌØÐÔ²»Í¬¶øÒ죬һ°ã±íÏÖΪËùʹÓÃÒ©ÎïµÄÒ©Àí×÷ÓÃÏà·´µÄÖ¢×´¡£ÀýÈç±½±û°·ÀàÐ˷ܼÁÒÀÀµ½ä¶Ïºó³öÏÖÎÞÁ¦¡¢Ë¼Ë¯¡¢ÇéÐ÷ÒÖÓôµÈÖ¢×´£»¶ø¾Æ¾«(ÖÐÊàÉñ¾ÏµÍ³ÒÖÖÆ¼Á)ÒÀÀµ½ä¶Ïºó³öÏÖÐË·Ü¡¢²»Ãߣ¬ÉõÖÁñ²ðïÑù·¢×÷µÈ±íÏÖ¡£ 47s
<xQy
ehQ"<.sQ
12¡¢³Éñ«(addiction) !|K~)4%rj
:X-Z|Pv8
50Äê´úÊÀ½çÎÀÉú×é֯ר¼ÒίԱ»á½«Ò©Îï³Éȳ¶¨ÒåΪ£º¡°ÓÉÓÚ·´¸´Ê¹ÓÃijÖÖÒ©ÎïËùÒýÆðµÄÒ»ÖÖÖÜÆÚÐÔ»òÂýÐÔÖж¾×´Ì¬£¬¾ßÓÐÒÔÏÂÌØÕ÷£º¢ÙÓÐÒ»ÖÖ²»¿É¿¹¾ÜµÄÁ¦Á¿Ç¿ÖÆÐÔµØÇýʹÈËÃÇʹÓøÃÒ©£¬²¢²»ÔñÊÖ¶ÎÈ¥»ñµÃËü£»¢ÚÓмӴó¼ÁÁ¿µÄÇ÷ÊÆ£»¢Û¶Ô¸ÃÒ©µÄЧӦ²úÉú¾«ÉñÒÀÀµ£¬Ò²¿É²úÉúÇûÌåÒÀÀµ£»¢Ü¶Ô¸öÈ˺ÍÉç»á¶¼²úÉúΣº¦¡£ÓÉÓÚ¡°³Éñ«¡±ÕâÒ»ÊõÓïÓÃ;̫¿í·º£¬ÊÀ½çÎÀÉú×éÖ¯½¨ÒéÓá°ÒÀÀµ¡±À´´úÌæ¡°³Éñ«¡±¡£ <H3 njv
(6i)m
c(
Growth cone£ºÉñ¾ÔªÖáÍ»ºÍÊ÷Í»Éú³¤µÄÄ©¶Ë±»³ÆÎªÉú³¤×µ¡££¬ÊÇÒ»Öָ߶ÈÄܶ¯µÄϸ°û½á¹¹ÌØ»¯ÐÎʽ£¬³Ê±¡µÄ±âƽĤ״£¬Éì³öһЩϸ³¤µÄ˿״α×ã×÷ΪÆäÑÓÉ첿·Ö---¼¡¶¯µ°°×¡£ Onoi ^MDy
pfS?:f<+6"
Ras»ùÒò£¬ÊÇÒ»ÖÖÔ°©»ùÒò£¬ÊÇÕý³£Ï¸°ûÖи߶ȱ£Êصġ°Ï¸°û»ùÒò¡±¡£ËüÓÉÄæ×ªÂ¼²¡¶¾»î»¯ºó¿ÉÒÔת»¯³ÉÓÐÖ°©ÄÜÁ¦µÄ°©»ùÒò¡£ÔÚÕý³£Ï¸°ûÖÐÓÐ3ÖÖrasÔ°©»ùÒò£¬C-Ha-ras, C-Ki-rasºÍC-N-ras¡£